Luca Agnelli
Cited by
Cited by
Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
F Cottini, T Hideshima, C Xu, M Sattler, M Dori, L Agnelli, E Ten Hacken, ...
Nature medicine 20 (6), 599-606, 2014
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
M Lionetti, M Biasiolo, L Agnelli, K Todoerti, L Mosca, S Fabris, G Sales, ...
Blood, The Journal of the American Society of Hematology 114 (25), e20-e26, 2009
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
N Amodio, MA Stamato, G Juli, E Morelli, M Fulciniti, M Manzoni, E Taiana, ...
Leukemia 32 (9), 1948-1957, 2018
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes
R Piva, E Pellegrino, M Mattioli, L Agnelli, L Lombardi, F Boccalatte, ...
The Journal of clinical investigation 116 (12), 3171-3182, 2006
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms
R Piva, L Agnelli, E Pellegrino, K Todoerti, V Grosso, I Tamagno, ...
Journal of clinical oncology 28 (9), 1583-1590, 2010
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target
M Bolzoni, M Chiu, F Accardi, R Vescovini, I Airoldi, P Storti, K Todoerti, ...
Blood, The Journal of the American Society of Hematology 128 (5), 667-679, 2016
Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations
L Agnelli, S Bicciato, M Mattioli, S Fabris, D Intini, D Verdelli, L Baldini, ...
Journal of clinical oncology 23 (29), 7296-7306, 2005
A SNP microarray and FISH‐based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect
L Agnelli, L Mosca, S Fabris, M Lionetti, A Andronache, I Kwee, K Todoerti, ...
Genes, Chromosomes and Cancer 48 (7), 603-614, 2009
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma
D Ronchetti, M Lionetti, L Mosca, L Agnelli, A Andronache, S Fabris, ...
BMC medical genomics 1, 1-9, 2008
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma
M Mattioli, L Agnelli, S Fabris, L Baldini, F Morabito, S Bicciato, D Verdelli, ...
Oncogene 24 (15), 2461-2473, 2005
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
P Storti, M Bolzoni, G Donofrio, I Airoldi, D Guasco, D Toscani, E Martella, ...
Leukemia 27 (8), 1697-1706, 2013
Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation
N Giuliani, M Ferretti, M Bolzoni, P Storti, M Lazzaretti, B Dalla Palma, ...
Leukemia 26 (6), 1391-1401, 2012
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma
L Agnelli, E Mereu, E Pellegrino, T Limongi, I Kwee, E Bergaggio, ...
Blood, The Journal of the American Society of Hematology 120 (6), 1274-1281, 2012
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts
I Scarf˛, E Pellegrino, E Mereu, I Kwee, L Agnelli, E Bergaggio, G Garaffo, ...
Blood, The Journal of the American Society of Hematology 127 (2), 221-232, 2016
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia
D Ronchetti, L Mosca, G Cutrona, G Tuana, M Gentile, S Fabris, L Agnelli, ...
BMC medical genomics 6, 1-11, 2013
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia
M Lionetti, P Musto, MT Di Martino, S Fabris, L Agnelli, K Todoerti, ...
Clinical cancer research 19 (12), 3130-3142, 2013
The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma
D Ronchetti, K Todoerti, G Tuana, L Agnelli, L Mosca, M Lionetti, S Fabris, ...
Blood cancer journal 2 (11), e96-e96, 2012
Revealing the impact of structural variants in multiple myeloma
EH Rustad, VD Yellapantula, D Glodzik, KH Maclachlan, B Diamond, ...
Blood cancer discovery 1 (3), 258-273, 2020
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
E Taiana, V Favasuli, D Ronchetti, K Todoerti, F Pelizzoni, M Manzoni, ...
Leukemia 34 (1), 234-244, 2020
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
E Minna, P Romeo, M Dugo, L De Cecco, K Todoerti, S Pilotti, F Perrone, ...
Oncotarget 7 (11), 12731, 2016
The system can't perform the operation now. Try again later.
Articles 1–20